Clinical Trial Update: Multicentre Trial Of Serum Levels Of MMP-9 As A Biomarker Of Endoleak

View source ↗

Summary

A multicenter clinical trial evaluated serum MMP-9 levels as a biomarker for endoleak after endovascular aneurysm repair; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Aortic Aneurysm
• Endoleak After Endovascular Aneurysm Repair

Snippet

Sponsor: Igor Koncar | Conditions: Endoleak After Endovascular Aneurysm Repair | Status: COMPLETED